| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Nachrichten zu Sanofi S.A.
|
04.09.13
|
|
|
30.08.13
|
|
|
29.08.13
|
|
|
26.08.13
|
|
|
26.08.13
|
|
|
06.08.13
|
|
|
05.08.13
|
|
|
01.08.13
|
|
|
01.08.13
|
Sanofi Q2 Profit Dips - Quick Facts (RTTNews)
|
|
01.08.13
|
Sanofi Q2 2013 - Interview with CEO Chris Viehbacher (Businesswire)
|
|
31.07.13
|
|
|
25.10.12
|
Sanofi Q3 2012 - Interview with CFO Jérôme Contamine (Businesswire)
|
|
26.07.12
|
Sanofi CEO Chris Viehbacher Comments on Results for Q2 2012 (Businesswire)
|
|
27.04.12
|
Sanofi CFO Jérôme Contamine Comments on Q1 2012 Results (Businesswire)
|
|
08.02.12
|
Sanofi CEO Chris Viehbacher Comments on 2011 Results (Businesswire)
|
|
01.03.11
|
|
|
01.02.11
|
|
|
20.09.10
|
|
|
16.06.10
|
|
|
12.01.10
|
Genzyme Reports Fourth-Quarter Revenue (Businesswire)
|
|
08.01.10
|
|
|
07.01.10
|
|
|
08.12.09
|
Robert J. Bertolini Elected to Genzyme’s Board of Directors (Businesswire)
|
|
07.12.09
|
|
|
06.10.09
|
Genzyme Receives FDA Complete Response Letter for Clolar (Businesswire)
|
|
23.09.09
|
Genzyme Provides Update on Cerezyme and Fabrazyme Supply (Businesswire)
|
|
10.07.09
|
|
|
01.06.09
|
|
|
19.03.09
|
|
|
29.01.09
|
|
|
29.01.09
|
|
|
13.01.09
|
|
|
11.12.08
|
|
|
09.12.08
|
|
|
05.12.08
|
|
|
14.11.08
|
|
|
10.09.07
|
|
|
07.11.05
|
|
|
12.09.05
|
|
|
05.04.05
|
|
|
10.03.05
|